Metronomic decitabine with venetoclax offers a patient-centered frontline therapeutic approach for TP53-mutated complex-karyotype myeloid neoplasms
Philip Hollingsworth Imus, Bruce Douglas Smith, William Brian Dalton, Royce P. Lee et al.
Journal
Haematologica
Topics
Acute Myeloid Leukemia Research
article
Metronomic decitabine with venetoclax offers a patient-centered frontline therapeutic approach for TP53-mutated complex-karyotype myeloid neoplasms
Philip Hollingsworth Imus, Bruce Douglas Smith, William Brian Dalton, Royce P. Lee, Alexander Joseph Ambinder, Amy Elizabeth Dezern, Arun Brendan Dutta, Ivana Gojo, Tania Jain, Howard Liu Li, Lukasz P. Gondek, Jonathan Allen Webster, Gabriel Ghiaur, Gabrielle T. Prince, Laura Frances Walsh, Mark J. Levis, Venkata Preetam Sandeep Kaduluri, Zachary Abrams, Theodoros Karatanos, Philip Payne, Joanathan Pan
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
University of Maryland, Baltimore (US), Johns Hopkins University (US), Washington University in St. Louis (US), Johns Hopkins Medicine (US)